Source: VAERS.HHS.GOV
VAERS accepts reports of adverse events and reactions that occur following vaccination. Healthcare providers, vaccine manufacturers, and the public can submit reports to the system. While very important in monitoring vaccine safety, VAERS reports alone cannot be used to determine if a vaccine caused or contributed to an adverse event or illness. The reports may contain information that is incomplete, inaccurate, coincidental, or unverifiable. In large part, reports to VAERS are voluntary, which means they are subject to biases. This creates specific limitations on how the data can be used scientifically. Data from VAERS reports should always be interpreted with these limitations in mind.
The strengths of VAERS are that it is national in scope and can quickly provide an early warning of a safety problem with a vaccine. As part of CDC and FDA’s multi-system approach to post-licensure vaccine safety monitoring, VAERS is designed to rapidly detect unusual or unexpected patterns of adverse events, also known as “safety signals.” If a safety signal is found in VAERS, further studies can be done in safety systems such as the CDC’s Vaccine Safety Datalink (VSD) or the Clinical Immunization Safety Assessment (CISA) project. These systems do not have the same scientific limitations as VAERS, and can better assess health risks and possible connections between adverse events and a vaccine.
Key considerations and limitations of VAERS data:
VAERS data available to the public include only the initial report data to VAERS. Updated data which contains data from medical records and corrections reported during follow up are used by the government for analysis. However, for numerous reasons including data consistency, these amended data are not available to the public.
FEVER & FACIAL ASYMMETRY; FEVER & FACIAL ASYMMETRY; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 23-Dec-2021 and was forwarded to Moderna on 24-Dec-2021. This regulatory authority case was reported by a consumer and describes the occurrence of PYREXIA (FEVER & FACIAL ASYMMETRY) and FACIAL ASYMMETRY (FEVER & FACIAL ASYMMETRY) in a 16-year-old female patient who received mRNA-1273 (COVID-19 Vaccine Moderna) (batch no. 939918) for an unknown indication. No Medical History information was reported. On 01-Dec-2021, the patient received dose of mRNA-1273 (COVID-19 Vaccine Moderna) (Intramuscular) 1 dosage form. On 01-Dec-2021 at 9:00 AM, the patient experienced PYREXIA (FEVER & FACIAL ASYMMETRY) (seriousness criterion hospitalization prolonged) and FACIAL ASYMMETRY (FEVER & FACIAL ASYMMETRY) (seriousness criterion hospitalization prolonged). At the time of the report, PYREXIA (FEVER & FACIAL ASYMMETRY) and FACIAL ASYMMETRY (FEVER & FACIAL ASYMMETRY) outcome was unknown. Not Provided The action taken with mRNA-1273 (COVID-19 Vaccine Moderna) (Intramuscular) was unknown. No concomitant medication was provided by reporter. No treatment drug was provided by reporter. Company Comment - This case concerns a 16 year old female patient with no relevant medical history, who experienced the serious (hospitalization) unexpected events of pyrexia and facial asymmetry. The events occurred on the same day after a dose of mRNA-1273 vaccine. The rechallenge was unknown. The benefit-risk relationship of the mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This case concerns a 16 year old female patient with no relevant medical history, who experienced the serious (hospitalization) unexpected events of pyrexia and facial asymmetry. The events occurred on the same day after a dose of mRNA-1273 vaccine. The rechallenge was unknown. The benefit-risk relationship of the mRNA-1273 vaccine is not affected by this report.
Open in Wayback Machine
(If this is a foreign report without a description you will be able to read the description in the Wayback Machine on Medalerts if the report became public for the first time before November 18, 2022.)
| Name | Dose # | Type | Manufacturer | Lot | Route | Site |
|---|---|---|---|---|---|---|
| COVID19 (COVID19 (MODERNA)) | 0 | COVID19 | MODERNA | 939918 | OT |
| RECVDATE: | 01-07-2022 | RPT_DATE: |
| CAGE_YR: | |
| CAGE_MO: | |
| DIED: | U |
| DATEDIED: | |
| L_THREAT: | U |
| ER_VISIT: | |
| HOSPITAL: | U |
| HOSPDAYS: | |
| X_STAY: | Y |
| DISABLE: | U |
| RECOVD: | U |
| LAB_DATA: | |
| V_ADMINBY: | |
| OTHER_MEDS: | |
| CUR_ILL: | |
| HISTORY: | |
| PRIOR_VAX: | |
| SPLTTYPE: | PHMODERNATX, INC.MOD20214 |
| FORM_VERS: | |
| TODAYS_DATE: | 01-05-2022 |
| BIRTH_DEFECT: | U |
| OFC_VISIT: | U |
| ER_ED_VISIT: | U |
| ALLERGIES: | |
| V_FUNDBY: |
Questions? Comments? Bugs?
[email protected]
Due to the high volume of inquiries, please be patient with response times.
AND PLEASE read the FAQ first.
OpenVAERS is a private organization that posts publicly available CDC/FDA data of injuries reported post-vaccination. Reports are not proof of causality.